Literature DB >> 18820849

[Asymmetric dimethylarginine (ADMA): A cardiovascular risk factor].

Friedrich Mittermayer1, Katarzyna Krzyzanowska, Michael Wolzt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18820849     DOI： 10.1007/s00508-008-0979-4

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  57 in total

1.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.

Authors:  J S Pollock; U Förstermann; J A Mitchell; T D Warner; H H Schmidt; M Nakane; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.

Authors:  Friedrich Mittermayer; Johannes Pleiner; Katarzyna Krzyzanowska; Günther F Wiesinger; Mario Francesconi; Michael Wolzt
Journal:  Wien Klin Wochenschr       Date:  2005-12       Impact factor: 1.704

3.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

4.  Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Authors:  Maria Lajer; Lise Tarnow; Anders Jorsal; Tom Teerlink; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2007-12-27       Impact factor: 19.112

5.  Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.

Authors:  Katarzyna Krzyzanowska; Friedrich Mittermayer; Michael Wolzt; Guntram Schernthaner
Journal:  Diabetes Care       Date:  2007-04-24       Impact factor: 19.112

Review 6.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.

Authors:  Jaw-Wen Chen; Nai-Wei Hsu; Tao-Cheng Wu; Shing-Jong Lin; Mau-Song Chang
Journal:  Am J Cardiol       Date:  2002-11-01       Impact factor: 2.778

8.  Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.

Authors:  Aaron S Kelly; Andrea M Thelen; Daniel R Kaiser; J Michael Gonzalez-Campoy; Alan J Bank
Journal:  Vasc Med       Date:  2007-11       Impact factor: 3.239

9.  Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.

Authors:  Osamu Suda; Masato Tsutsui; Tsuyoshi Morishita; Hiromi Tasaki; Susumu Ueno; Sei Nakata; Takashi Tsujimoto; Yumiko Toyohira; Yoshiaki Hayashida; Yasuyuki Sasaguri; Yoichi Ueta; Yasuhide Nakashima; Nobuyuki Yanagihara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-06-24       Impact factor: 8.311

10.  Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.

Authors:  Tse-Min Lu; Yu-An Ding; Shing-Jong Lin; Wen-Shin Lee; Ho-Charng Tai
Journal:  Eur Heart J       Date:  2003-11       Impact factor: 29.983
View more
  1 in total

1.  Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis.

Authors:  Dejan Spasovski; Arif Latifi; Bashkim Osmani; Svetlana Krstevska-Balkanov; Irena Kafedizska; Maja Slaninka-Micevska; Beti Dejanova; Sonja Alabakovska; Trajan Balkanov
Journal:  Arthritis       Date:  2013-05-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.